Tandem Diabetes Care (TNDM) Operating Expenses (2013 - 2026)

Tandem Diabetes Care's Operating Expenses history runs 14 years deep, the most recent figure standing at $154.2 million for Q1 2026.

• Quarterly Operating Expenses fell 35.55% year-over-year to $154.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $648.2 million (down 6.28% YoY) and the FY2025 annual result came in at $733.3 million, up 24.56% from the prior year.
• Operating Expenses was $154.2 million for Q1 2026 at Tandem Diabetes Care, down from $159.2 million in the prior quarter.
• Across five years, Operating Expenses topped out at $239.3 million in Q1 2025 and bottomed at $106.4 million in Q1 2022.
• A 5-year average of $151.9 million and a median of $150.7 million in 2024 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2023 — Operating Expenses soared 97.99% — and 2026, when it plunged 35.55%.
• Tandem Diabetes Care's Operating Expenses stood at $133.3 million in 2022, then declined by 3.71% to $128.4 million in 2023, then rose by 23.12% to $158.0 million in 2024, then climbed by 0.72% to $159.2 million in 2025, then dropped by 3.11% to $154.2 million in 2026.
• Business Quant data shows TNDM's Operating Expenses at $154.2 million in Q1 2026, $159.2 million in Q4 2025, and $157.2 million in Q3 2025.